Chemotherapy drug shortages in the united states: Genesis and potential solutions

Journal of Clinical Oncology

Volumn 30, Issue 7, 2012, Pages 692-694

  Link, Michael P ^a   Hagerty, Karen ^b   Kantarjian, Hagop M ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORMETHINE; CISPLATIN; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GENERIC DRUG; PACLITAXEL;

ACUTE GRANULOCYTIC LEUKEMIA; AWARENESS; DRUG CONTAMINATION; DRUG COST; DRUG INDUSTRY; DRUG SHORTAGE; LEUKEMIA; MEDICARE; NOTE; PRIORITY JOURNAL; REIMBURSEMENT; UNITED STATES;

ANTINEOPLASTIC AGENTS; CYTARABINE; HUMANS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84857531041     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.41.0936     Document Type: Note

References (12)

1. US Food and Drug Administration: Drug shortages. http://www.fda.gov/ Drugs/DrugSafety/DrugShortages/default.htm
2. Emanuel E: Cancer drugs, effective but scarce. New York Times, August 7, 2011, p SR1, http://www.nytimes.com/2011/08/07/opinion/sunday/ezekielemanuel- cancer-patients.html
3. Review and outlook: The Bush-Obama Rx shortages. Wall Street Journal, November 2, 2011, p 11, http://online.wsj.com/article/ SB10001424052970204394804577012013740860768.htm
4. Gatesman M, Smith T: The shortage of essential chemotherapy drugs in the United States. N Engl J Med 365:1653-1655, 2011
5. Chabner BA: Drug shortages: A critical challenge for the generic-drug market. N Engl J Med 365:2147-2149, 2011
6. Silverman E: Why a Boehringer unit really has drug shortages. http://www.pharmalot.com/2011/06/why-a-boehringer-unit-really-has-drug- shortages/
7. Centers for Medicare and Medicaid Services: Medicare Part B drugs regulations. http://www.cms.gov/McrPartBDrugAvgSalesPrice/03-regulations.asp
8. Twombly R: Medicare cost containment strategy targets several oncology drugs. J Natl Cancer Inst 96:1268-1270, 2004
9. Assistant Secretary for Planning and Evaluation, US Department of Health and Human Services: ASPE Issue Brief: Economic analysis of the causes of drug shortages. http://aspe.hhs.gov/sp/reports/2011/DrugShortages/ib.shtml
10. Cherici C, McGinnis P, Russell W: Buyer beware: Drug shortages and the gray market. http://www.premierinc.com/about/news/11-aug/Gray-Market/Gray- Market-Analysis-08152011.pdf
11. Generic Pharmaceutical Association: An economic analysis of generic drug usage in the United States. http://gphaonline.org/sites/default/files/ GPhA%20IMS%20Study%20WEB%20Sep20%2011.pdf
12. Kaakeh R, Sweet BV, Reilly C, et al: Impact of drug shortages on U.S. health systems. Am J Health Syst Pharm 68:1811-1819, 2011